EME. R. McFadden

E. R. McFadden

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


E. R. McFadden has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Albert J. Coreno

    Division of Pulmonary, Critical Care, and Sleep Medicine, and Department of Medicine, MetroHealth Medical Center, and Center for Academic Clinical Research, and General Clinical Research Center, Case Western Reserve University School of Medicine, Cleveland, Ohio

    2 shared publications
  • Mary E. Skowronski

    Division of Pulmonary, Critical Care, and Sleep Medicine, and Department of Medicine, MetroHealth Medical Center, and Center for Academic Clinical Research, and General Clinical Research Center, Case Western Reserve University School of Medicine, Cleveland, Ohio

    2 shared publications
  • Aishwarya Palwai

    Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine of MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH 44109, USA

    1 shared publication
  • Albert Coreno

    Division of Pulmonary, Critical Care and Sleep Medicine and the Department of Medicine of MetroHealth Medical Center, Cleveland, Ohio; and 2General Clinical Research Center of Case Western Reserve University School of Medicine Department of BioMedical Engineering, Cleveland, Ohio

    1 shared publication
  • Amr El-Ekiaby

    Division of Pulmonary, Critical Care, and Sleep Medicine, Cleveland, OH 44109, USA

    1 shared publication
  • Colin K. Drummond

    Case Western Reserve University, USA

    1 shared publication

Latest Publications

  • Critical Comparisons of the Clinical Performance of Oxygen-conserving Devices

    by Aishwarya Palwai, Mary Skowronski, Albert Coreno, Colin Drummond, E. R. McFadden

    Rationale: Clinical testing of oxygen-conserving devices is not mandated before marketing. Consequently, little is known about individual or comparative therapeutic effectiveness. Objectives: To relate oxygen delivery from prototypical instruments to physiological performance. Methods: Thirteen subjects with obstructive lung disease performed progressive treadmill exercise while inhaling either room air, 2 L O2/min, or bolus oxygen from four commercially available conserving devices at regulator settings of 2, 5, and continuous. The devices were studied blindly in random order after first being tested to determine performance characteristics. Pulse oximetry, oxygen delivery, and nasal and oral ventilations were monitored at rest and with exertion. Measurements and Main Results: At a setting of 2 at rest, all conservers maintained saturation greater than 90%, but there were significant differences in oxygenation between systems. Only one equaled 2 L O2/min. With exertion, saturation decreased with all conservers but not with 2 L O2/min. One device did not perform any better than room air. Two systems provided less oxygen than predicted, one more, and in one the expected and actual amounts were equal only at rest. Breath-by-breath performance was highly variable, with irregular activation and inconsistent oxygen bolus size delivery. Increasing oxygen pulse volume to the point of eradicating conservation with the continuous setting did not eliminate all disparities. Conclusions: The mechanical and clinical performances of current oxygen conservers are highly variable and in some instances actually contribute to limitations in exercise ability. Seemingly equivalent technical features do not guarantee equivalent therapeutic functionality.


  • Observations on the physiological interactions between obesity and asthma

    by Katina Nicolacakis, Mary E. Skowronski, Albert J. Coreno, Erin West, Nizar Z. Nader, Robert L. Smith, E. R. McFadden

    To explore whether asthma and obesity share overlapping pathogenic features, we examined the impact of each alone, and in combination, on multiple aspects of lung function. We reasoned that if they influenced the lungs through similar mechanisms, the individual physiological manifestations in the comorbid state should interact in a complex fashion. If not, then the abnormalities should simply add. We measured specific conductance, spirometry, lung volumes, and airway responsiveness to adrenergic and cholinergic agonists in 52 normal, 53 asthmatic, 52 obese, and 53 asthmatic and obese patients using standard techniques. Six-minute walks were performed in subsets from each group. Asthma significantly lowered specific conductance and the spirometric variables while increasing airway reactivity and residual volume. Obesity also reduced the spirometric variables as well as total lung capacity and functional residual capacity. Residual volume, specific conductance, and airway responsivity were unaltered. With comorbidity, the disease-specific derangements added algebraically. Features that existed in isolation appeared unchanged in the combination, whereas shared ones either added or subtracted depending on the individual directional changes. Synergistic interactions were not observed. Body mass index weakly correlated with spirometry and lung volumes in asthma, but not with specific conductance or bronchial reactivity. Exercise performance did not aid in differentiation. Our findings indicate asthma and obesity appear to influence the respiratory system through different processes.


  • Impact of Race on the Severity of Acute Episodes of Asthma and Adrenergic Responsiveness

    by Amr El-Ekiaby, Lori Brianas, Mary E. Skowronski, Albert J. Coreno, Gayle Galan, Frank J. Kaeberlein, Roy E. Seitz, Karen D. Villaba, Howard Dickey-White, E. R. McFadden

    Rationale: African Americans acutely ill with asthma come to emergency departments more frequently and are admitted to hospital more often than whites but the reasons are unclear. Objectives: To determine whether such phenomena represent racial differences in attack severity or limited effectiveness of β2-agonist therapy. Methods and Main Results: We contrasted clinical features, airflow limitation, and albuterol responsiveness in adults acutely ill with asthma, 155 of whom where African American and 140 white, as they presented to eight emergency departments. Assessments were standardized across institutions using a care path, and admission and discharge decisions were made according to predetermined criteria. The degree of obstruction was measured by peak expiratory flow rates. The clinical features of both groups were similar. The African Americans, however, had lower flow rates (p = 0.002), and more of them experienced severe or potentially life threatening episodes (p < 0.001). Albuterol was equally efficacious in both populations and there were no differences in the post-treatment flow rates achieved irrespective of the initial attack intensity. There were no racial differences in admission/discharge ratios. Conclusions: Our data indicate that African Americans with asthma tend to present with somewhat more intense attacks than whites, but they respond equally well to routine treatment. Similarly, there were no racial disparities in hospitalizations when standard criteria are employed.